242 related articles for article (PubMed ID: 27795744)
1. Global DNA methylation patterns in Barrett's esophagus, dysplastic Barrett's, and esophageal adenocarcinoma are associated with BMI, gender, and tobacco use.
Kaz AM; Wong CJ; Varadan V; Willis JE; Chak A; Grady WM
Clin Epigenetics; 2016; 8():111. PubMed ID: 27795744
[TBL] [Abstract][Full Text] [Related]
2. Identification of a key role of widespread epigenetic drift in Barrett's esophagus and esophageal adenocarcinoma.
Luebeck EG; Curtius K; Hazelton WD; Maden S; Yu M; Thota PN; Patil DT; Chak A; Willis JE; Grady WM
Clin Epigenetics; 2017; 9():113. PubMed ID: 29046735
[TBL] [Abstract][Full Text] [Related]
3. Identification of Subtypes of Barrett's Esophagus and Esophageal Adenocarcinoma Based on DNA Methylation Profiles and Integration of Transcriptome and Genome Data.
Jammula S; Katz-Summercorn AC; Li X; Linossi C; Smyth E; Killcoyne S; Biasci D; Subash VV; Abbas S; Blasko A; Devonshire G; Grantham A; Wronowski F; O'Donovan M; Grehan N; Eldridge MD; Tavaré S; ; Fitzgerald RC
Gastroenterology; 2020 May; 158(6):1682-1697.e1. PubMed ID: 32032585
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide methylation analysis shows similar patterns in Barrett's esophagus and esophageal adenocarcinoma.
Xu E; Gu J; Hawk ET; Wang KK; Lai M; Huang M; Ajani J; Wu X
Carcinogenesis; 2013 Dec; 34(12):2750-6. PubMed ID: 23996928
[TBL] [Abstract][Full Text] [Related]
5. Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma.
Agarwal A; Polineni R; Hussein Z; Vigoda I; Bhagat TD; Bhattacharyya S; Maitra A; Verma A
Int J Clin Exp Pathol; 2012; 5(5):382-96. PubMed ID: 22808291
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of the AKAP12 promoter is a biomarker of Barrett's-associated esophageal neoplastic progression.
Jin Z; Hamilton JP; Yang J; Mori Y; Olaru A; Sato F; Ito T; Kan T; Cheng Y; Paun B; David S; Beer DG; Agarwal R; Abraham JM; Meltzer SJ
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):111-7. PubMed ID: 18199717
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation profiling in Barrett's esophagus and esophageal adenocarcinoma reveals unique methylation signatures and molecular subclasses.
Kaz AM; Wong CJ; Luo Y; Virgin JB; Washington MK; Willis JE; Leidner RS; Chak A; Grady WM
Epigenetics; 2011 Dec; 6(12):1403-12. PubMed ID: 22139570
[TBL] [Abstract][Full Text] [Related]
8. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation as an adjunct to histopathology to detect prevalent, inconspicuous dysplasia and early-stage neoplasia in Barrett's esophagus.
Alvi MA; Liu X; O'Donovan M; Newton R; Wernisch L; Shannon NB; Shariff K; di Pietro M; Bergman JJ; Ragunath K; Fitzgerald RC
Clin Cancer Res; 2013 Feb; 19(4):878-88. PubMed ID: 23243219
[TBL] [Abstract][Full Text] [Related]
10. Genetic and Epigenetic Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma.
Kaz AM; Grady WM; Stachler MD; Bass AJ
Gastroenterol Clin North Am; 2015 Jun; 44(2):473-89. PubMed ID: 26021206
[TBL] [Abstract][Full Text] [Related]
11. Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study.
Thrift AP; Shaheen NJ; Gammon MD; Bernstein L; Reid BJ; Onstad L; Risch HA; Liu G; Bird NC; Wu AH; Corley DA; Romero Y; Chanock SJ; Chow WH; Casson AG; Levine DM; Zhang R; Ek WE; MacGregor S; Ye W; Hardie LJ; Vaughan TL; Whiteman DC
J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25269698
[TBL] [Abstract][Full Text] [Related]
12. Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma.
Smith E; De Young NJ; Pavey SJ; Hayward NK; Nancarrow DJ; Whiteman DC; Smithers BM; Ruszkiewicz AR; Clouston AD; Gotley DC; Devitt PG; Jamieson GG; Drew PA
Mol Cancer; 2008 Oct; 7():75. PubMed ID: 18831746
[TBL] [Abstract][Full Text] [Related]
13. Hypomethylation of noncoding DNA regions and overexpression of the long noncoding RNA, AFAP1-AS1, in Barrett's esophagus and esophageal adenocarcinoma.
Wu W; Bhagat TD; Yang X; Song JH; Cheng Y; Agarwal R; Abraham JM; Ibrahim S; Bartenstein M; Hussain Z; Suzuki M; Yu Y; Chen W; Eng C; Greally J; Verma A; Meltzer SJ
Gastroenterology; 2013 May; 144(5):956-966.e4. PubMed ID: 23333711
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk.
Schulmann K; Sterian A; Berki A; Yin J; Sato F; Xu Y; Olaru A; Wang S; Mori Y; Deacu E; Hamilton J; Kan T; Krasna MJ; Beer DG; Pepe MS; Abraham JM; Feng Z; Schmiegel W; Greenwald BD; Meltzer SJ
Oncogene; 2005 Jun; 24(25):4138-48. PubMed ID: 15824739
[TBL] [Abstract][Full Text] [Related]
15. Aberrantly methylated PKP1 in the progression of Barrett's esophagus to esophageal adenocarcinoma.
Kaz AM; Luo Y; Dzieciatkowski S; Chak A; Willis JE; Upton MP; Leidner RS; Grady WM
Genes Chromosomes Cancer; 2012 Apr; 51(4):384-93. PubMed ID: 22170739
[TBL] [Abstract][Full Text] [Related]
16. Subtypes of Barrett's oesophagus and oesophageal adenocarcinoma based on genome-wide methylation analysis.
Yu M; Maden SK; Stachler M; Kaz AM; Ayers J; Guo Y; Carter KT; Willbanks A; Heinzerling TJ; O'Leary RM; Xu X; Bass A; Chandar AK; Chak A; Elliott R; Willis JE; Markowitz SD; Grady WM
Gut; 2019 Mar; 68(3):389-399. PubMed ID: 29884612
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinoma.
Ek WE; Lagergren K; Cook M; Wu AH; Abnet CC; Levine D; Chow WH; Bernstein L; Risch HA; Shaheen NJ; Bird NC; Corley DA; Hardie LJ; Fitzgerald RC; Gammon MD; Romero Y; Liu G; Ye W; Vaughan TL; MacGregor S; Whiteman DC; Westberg L; Lagergren J
Int J Cancer; 2016 Mar; 138(5):1146-52. PubMed ID: 26414697
[TBL] [Abstract][Full Text] [Related]
18. Targeted genetic and epigenetic profiling of esophageal adenocarcinomas and non-dysplastic Barrett's esophagus.
Pinto R; Hauge T; Jeanmougin M; Pharo HD; Kresse SH; Honne H; Winge SB; Five MB; Kumar T; Mala T; Hauge T; Johnson E; Lind GE
Clin Epigenetics; 2022 Jun; 14(1):77. PubMed ID: 35701814
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic biomarkers in esophageal cancer.
Kaz AM; Grady WM
Cancer Lett; 2014 Jan; 342(2):193-9. PubMed ID: 22406828
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive DNA methylation profiling of Barrett's esophagus and esophageal adenocarcinoma in Japanese patients.
Shijimaya T; Tahara T; Yamazaki J; Matsumoto Y; Nakamura N; Takahashi Y; Tomiyama T; Fukui T; Shibata T; Naganuma M
Mol Carcinog; 2023 Aug; 62(8):1191-1200. PubMed ID: 37204209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
